Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

NCT04786964 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Regional political conflict

Conditions

Metastatic Non-squamous Non Small Cell Lung Cancer

Interventions

DRUG: Cosibelimab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
DIETARY_SUPPLEMENT: Folic acid 350-1000 μg
DIETARY_SUPPLEMENT: Vitamin B12 1000 μg
DRUG: Dexamethasone 4mg

Sponsor

Checkpoint Therapeutics, Inc.